Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to evaluate if high-dose (80mg/day) atorvastatin might exert an adjunctive anti-platelet effect compared to high-dose clopidogrel (150mg/day) in stable patients with high on-treatment reactivity according to a point-of-care platelet function assay.
Epistemonikos ID: 8063d53a89253a47c9c29ff52ff2777447369b0f
First added on: May 06, 2024